Growing demand for obesity is one of the recent trends in the global Anti-Obesity Prescription Drugs market. Moreover, this trend is further anticipated to drive the global Anti-Obesity Prescription Drugs market over the forecast period. Furthermore, growing obesity due unhealthy food and lifestyle such as intake of drugs due to stress, alcohol leads to growing demand for obesity management resulting in growth of this trend.
Scope of the Report:
This report focuses on the Anti-Obesity Prescription Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The worldwide market for Anti-Obesity Prescription Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
- F Hoffmann La Roche Ltd
- Orexigen Therapeutics, Inc
- Novo Nordisk A/s
- Arena Pharmaceuticals, Inc
- Glaxosmithkline
- Vivus, Inc
- Boehringer Ingelheim
- Alizyme
Market Segment by Regions, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
- Orlistat
- Phentermine and Topiramate
- Bupropion and Naltrexone
- Lorcaserin
- Liraglutide
Market Segment by Applications, can be divided into
- Pediatric
- Adult
There are 15 Chapters to deeply display the global Anti-Obesity Prescription Drugs market.
Chapter 1, to describe Anti-Obesity Prescription Drugs Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Anti-Obesity Prescription Drugs, with sales, revenue, and price of Anti-Obesity Prescription Drugs, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Anti-Obesity Prescription Drugs, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Anti-Obesity Prescription Drugs market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Anti-Obesity Prescription Drugs sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Anti-Obesity Prescription Drugs Market 2018, Forecast to 2023
Table of Contents
1 Market Overview
1.1 Anti-Obesity Prescription Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Orlistat
1.2.2 Phentermine and Topiramate
1.2.3 Bupropion and Naltrexone
1.2.4 Lorcaserin
1.2.5 Liraglutide
1.3 Market Analysis by Applications
1.3.1 Pediatric
1.3.2 Adult
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 F Hoffmann La Roche Ltd
2.1.1 Business Overview
2.1.1.1 F Hoffmann La Roche Ltd Description
2.1.1.2 F Hoffmann La Roche Ltd Headquarter, Main Business and Finance Overview
2.1.2 F Hoffmann La Roche Ltd Anti-Obesity Prescription Drugs Product Introduction
2.1.2.1 Anti-Obesity Prescription Drugs Production Bases, Sales Regions and Major Competitors
2.1.2.2 Anti-Obesity Prescription Drugs Product Information
2.1.3 F Hoffmann La Roche Ltd Anti-Obesity Prescription Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.1 F Hoffmann La Roche Ltd Anti-Obesity Prescription Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.2 Global F Hoffmann La Roche Ltd Anti-Obesity Prescription Drugs Market Share in 2017
2.2 Orexigen Therapeutics, Inc
2.2.1 Business Overview
2.2.1.1 Orexigen Therapeutics, Inc Description
2.2.1.2 Orexigen Therapeutics, Inc Headquarter, Main Business and Finance Overview
2.2.2 Orexigen Therapeutics, Inc Anti-Obesity Prescription Drugs Product Introduction
2.2.2.1 Anti-Obesity Prescription Drugs Production Bases, Sales Regions and Major Competitors
2.2.2.2 Anti-Obesity Prescription Drugs Product Information
2.2.3 Orexigen Therapeutics, Inc Anti-Obesity Prescription Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.1 Orexigen Therapeutics, Inc Anti-Obesity Prescription Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.2 Global Orexigen Therapeutics, Inc Anti-Obesity Prescription Drugs Market Share in 2017
2.3 Novo Nordisk A/s
2.3.1 Business Overview
2.3.1.1 Novo Nordisk A/s Description
2.3.1.2 Novo Nordisk A/s Headquarter, Main Business and Finance Overview
2.3.2 Novo Nordisk A/s Anti-Obesity Prescription Drugs Product Introduction
2.3.2.1 Anti-Obesity Prescription Drugs Production Bases, Sales Regions and Major Competitors
2.3.2.2 Anti-Obesity Prescription Drugs Product Information
2.3.3 Novo Nordisk A/s Anti-Obesity Prescription Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.3.1 Novo Nordisk A/s Anti-Obesity Prescription Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.3.2 Global Novo Nordisk A/s Anti-Obesity Prescription Drugs Market Share in 2017
2.4 Arena Pharmaceuticals, Inc
2.4.1 Business Overview
2.4.1.1 Arena Pharmaceuticals, Inc Description
2.4.1.2 Arena Pharmaceuticals, Inc Headquarter, Main Business and Finance Overview
2.4.2 Arena Pharmaceuticals, Inc Anti-Obesity Prescription Drugs Product Introduction
2.4.2.1 Anti-Obesity Prescription Drugs Production Bases, Sales Regions and Major Competitors
2.4.2.2 Anti-Obesity Prescription Drugs Product Information
2.4.3 Arena Pharmaceuticals, Inc Anti-Obesity Prescription Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.3.1 Arena Pharmaceuticals, Inc Anti-Obesity Prescription Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.3.2 Global Arena Pharmaceuticals, Inc Anti-Obesity Prescription Drugs Market Share in 2017
2.5 Glaxosmithkline
2.5.1 Business Overview
2.5.1.1 Glaxosmithkline Description
2.5.1.2 Glaxosmithkline Headquarter, Main Business and Finance Overview
2.5.2 Glaxosmithkline Anti-Obesity Prescription Drugs Product Introduction
2.5.2.1 Anti-Obesity Prescription Drugs Production Bases, Sales Regions and Major Competitors
2.5.2.2 Anti-Obesity Prescription Drugs Product Information
2.5.3 Glaxosmithkline Anti-Obesity Prescription Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.3.1 Glaxosmithkline Anti-Obesity Prescription Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.3.2 Global Glaxosmithkline Anti-Obesity Prescription Drugs Market Share in 2017
2.6 Vivus, Inc
2.6.1 Business Overview
2.6.1.1 Vivus, Inc Description
2.6.1.2 Vivus, Inc Headquarter, Main Business and Finance Overview
2.6.2 Vivus, Inc Anti-Obesity Prescription Drugs Product Introduction
2.6.2.1 Anti-Obesity Prescription Drugs Production Bases, Sales Regions and Major Competitors
2.6.2.2 Anti-Obesity Prescription Drugs Product Information
2.6.3 Vivus, Inc Anti-Obesity Prescription Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.3.1 Vivus, Inc Anti-Obesity Prescription Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.3.2 Global Vivus, Inc Anti-Obesity Prescription Drugs Market Share in 2017
2.7 Boehringer Ingelheim
2.7.1 Business Overview
2.7.1.1 Boehringer Ingelheim Description
2.7.1.2 Boehringer Ingelheim Headquarter, Main Business and Finance Overview
2.7.2 Boehringer Ingelheim Anti-Obesity Prescription Drugs Product Introduction
2.7.2.1 Anti-Obesity Prescription Drugs Production Bases, Sales Regions and Major Competitors
2.7.2.2 Anti-Obesity Prescription Drugs Product Information
2.7.3 Boehringer Ingelheim Anti-Obesity Prescription Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.3.1 Boehringer Ingelheim Anti-Obesity Prescription Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.3.2 Global Boehringer Ingelheim Anti-Obesity Prescription Drugs Market Share in 2017
2.8 Alizyme
2.8.1 Business Overview
2.8.1.1 Alizyme Description
2.8.1.2 Alizyme Headquarter, Main Business and Finance Overview
2.8.2 Alizyme Anti-Obesity Prescription Drugs Product Introduction
2.8.2.1 Anti-Obesity Prescription Drugs Production Bases, Sales Regions and Major Competitors
2.8.2.2 Anti-Obesity Prescription Drugs Product Information
2.8.3 Alizyme Anti-Obesity Prescription Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8.3.1 Alizyme Anti-Obesity Prescription Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8.3.2 Global Alizyme Anti-Obesity Prescription Drugs Market Share in 2017
3 Global Anti-Obesity Prescription Drugs Market Competition, by Manufacturer
3.1 Global Anti-Obesity Prescription Drugs Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Anti-Obesity Prescription Drugs Revenue and Market Share by Manufacturer (2016-2017)
3.3 Global Anti-Obesity Prescription Drugs Price by Manufacturer (2016-2017)
3.4 Market Concentration Rate
3.4.1 Top 3 Anti-Obesity Prescription Drugs Manufacturer Market Share in 2017
3.4.2 Top 5 Anti-Obesity Prescription Drugs Manufacturer Market Share in 2017
3.5 Market Competition Trend
4 Global Anti-Obesity Prescription Drugs Market Analysis by Regions
4.1 Global Anti-Obesity Prescription Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global Anti-Obesity Prescription Drugs Sales by Regions (2013-2018)
4.1.2 Global Anti-Obesity Prescription Drugs Revenue by Regions (2013-2018)
4.2 North America Anti-Obesity Prescription Drugs Sales, Revenue and Growth Rate (2013-2018)
4.3 Europe Anti-Obesity Prescription Drugs Sales, Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Anti-Obesity Prescription Drugs Sales, Revenue and Growth Rate (2013-2018)
4.5 South America Anti-Obesity Prescription Drugs Sales, Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Anti-Obesity Prescription Drugs Sales, Revenue and Growth Rate (2013-2018)
5 North America Anti-Obesity Prescription Drugs by Countries, Type, Application and Manufacturers
5.1 North America Anti-Obesity Prescription Drugs Sales, Revenue and Market Share by Countries
5.1.1 North America Anti-Obesity Prescription Drugs Sales by Countries (2013-2018)
5.1.2 North America Anti-Obesity Prescription Drugs Revenue by Countries (2013-2018)
5.1.3 United States Anti-Obesity Prescription Drugs Sales and Growth Rate (2013-2018)
5.1.4 Canada Anti-Obesity Prescription Drugs Sales and Growth Rate (2013-2018)
5.1.5 Mexico Anti-Obesity Prescription Drugs Sales and Growth Rate (2013-2018)
5.2 North America Anti-Obesity Prescription Drugs Sales and Revenue (Value) by Manufacturers (2016-2017)
5.2.1 North America Anti-Obesity Prescription Drugs Sales by Manufacturers (2016-2017)
5.2.2 North America Anti-Obesity Prescription Drugs Revenue by Manufacturers (2016-2017)
5.3 North America Anti-Obesity Prescription Drugs Sales, Revenue and Market Share by Type (2013-2018)
5.3.1 North America Anti-Obesity Prescription Drugs Sales and Sales Share by Type (2013-2018)
5.3.2 North America Anti-Obesity Prescription Drugs Revenue and Revenue Share by Type (2013-2018)
5.4 North America Anti-Obesity Prescription Drugs Sales, Revenue and Market Share by Application (2013-2018)
5.4.1 North America Anti-Obesity Prescription Drugs Sales and Sales Share by Application (2013-2018)
5.4.2 North America Anti-Obesity Prescription Drugs Revenue and Revenue Share by Application (2013-2018)
6 Europe Anti-Obesity Prescription Drugs by Countries, Type, Application and Manufacturers
6.1 Europe Anti-Obesity Prescription Drugs Sales, Revenue and Market Share by Countries
6.1.1 Europe Anti-Obesity Prescription Drugs Sales by Countries (2013-2018)
6.1.2 Europe Anti-Obesity Prescription Drugs Revenue by Countries (2013-2018)
6.1.3 Germany Anti-Obesity Prescription Drugs Sales and Growth Rate (2013-2018)
6.1.4 UK Anti-Obesity Prescription Drugs Sales and Growth Rate (2013-2018)
6.1.5 France Anti-Obesity Prescription Drugs Sales and Growth Rate (2013-2018)
6.1.6 Russia Anti-Obesity Prescription Drugs Sales and Growth Rate (2013-2018)
6.1.7 Italy Anti-Obesity Prescription Drugs Sales and Growth Rate (2013-2018)
6.2 Europe Anti-Obesity Prescription Drugs Sales and Revenue (Value) by Manufacturers (2016-2017)
6.2.1 Europe Anti-Obesity Prescription Drugs Sales by Manufacturers (2016-2017)
6.2.2 Europe Anti-Obesity Prescription Drugs Revenue by Manufacturers (2016-2017)
6.3 Europe Anti-Obesity Prescription Drugs Sales, Revenue and Market Share by Type (2013-2018)
6.3.1 Europe Anti-Obesity Prescription Drugs Sales and Sales Share by Type (2013-2018)
6.3.2 Europe Anti-Obesity Prescription Drugs Revenue and Revenue Share by Type (2013-2018)
6.4 Europe Anti-Obesity Prescription Drugs Sales, Revenue and Market Share by Application (2013-2018)
6.4.1 Europe Anti-Obesity Prescription Drugs Sales and Sales Share by Application (2013-2018)
6.4.2 Europe Anti-Obesity Prescription Drugs Revenue and Revenue Share by Application (2013-2018)
7 Asia-Pacific Anti-Obesity Prescription Drugs by Countries, Type, Application and Manufacturers
7.1 Asia-Pacific Anti-Obesity Prescription Drugs Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Anti-Obesity Prescription Drugs Sales by Countries (2013-2018)
7.1.2 Asia-Pacific Anti-Obesity Prescription Drugs Revenue by Countries (2013-2018)
7.1.3 China Anti-Obesity Prescription Drugs Sales and Growth Rate (2013-2018)
7.1.4 Japan Anti-Obesity Prescription Drugs Sales and Growth Rate (2013-2018)
7.1.5 Korea Anti-Obesity Prescription Drugs Sales and Growth Rate (2013-2018)
7.1.6 India Anti-Obesity Prescription Drugs Sales and Growth Rate (2013-2018)
7.1.7 Southeast Asia Anti-Obesity Prescription Drugs Sales and Growth Rate (2013-2018)
7.2 Asia-Pacific Anti-Obesity Prescription Drugs Sales and Revenue (Value) by Manufacturers (2016-2017)
7.2.1 Asia-Pacific Anti-Obesity Prescription Drugs Sales by Manufacturers (2016-2017)
7.2.2 Asia-Pacific Anti-Obesity Prescription Drugs Revenue by Manufacturers (2016-2017)
7.3 Asia-Pacific Anti-Obesity Prescription Drugs Sales, Revenue and Market Share by Type (2013-2018)
7.3.1 Asia-Pacific Anti-Obesity Prescription Drugs Sales and Sales Share by Type (2013-2018)
7.3.2 Asia-Pacific Anti-Obesity Prescription Drugs Revenue and Revenue Share by Type (2013-2018)
7.4 Asia-Pacific Anti-Obesity Prescription Drugs Sales, Revenue and Market Share by Application (2013-2018)
7.4.1 Asia-Pacific Anti-Obesity Prescription Drugs Sales and Sales Share by Application (2013-2018)
7.4.2 Asia-Pacific Anti-Obesity Prescription Drugs Revenue and Revenue Share by Application (2013-2018)
8 South America Anti-Obesity Prescription Drugs by Countries, Type, Application and Manufacturers
8.1 South America Anti-Obesity Prescription Drugs Sales, Revenue and Market Share by Countries
8.1.1 South America Anti-Obesity Prescription Drugs Sales by Countries (2013-2018)
8.1.2 South America Anti-Obesity Prescription Drugs Revenue by Countries (2013-2018)
8.1.3 Brazil Anti-Obesity Prescription Drugs Sales and Growth Rate (2013-2018)
8.1.4 Argentina Anti-Obesity Prescription Drugs Sales and Growth Rate (2013-2018)
8.1.5 Colombia Anti-Obesity Prescription Drugs Sales and Growth Rate (2013-2018)
8.2 South America Anti-Obesity Prescription Drugs Sales and Revenue (Value) by Manufacturers (2016-2017)
8.2.1 South America Anti-Obesity Prescription Drugs Sales by Manufacturers (2016-2017)
8.2.2 South America Anti-Obesity Prescription Drugs Revenue by Manufacturers (2016-2017)
8.3 South America Anti-Obesity Prescription Drugs Sales, Revenue and Market Share by Type (2013-2018)
8.3.1 South America Anti-Obesity Prescription Drugs Sales and Sales Share by Type (2013-2018)
8.3.2 South America Anti-Obesity Prescription Drugs Revenue and Revenue Share by Type (2013-2018)
8.4 South America Anti-Obesity Prescription Drugs Sales, Revenue and Market Share by Application (2013-2018)
8.4.1 South America Anti-Obesity Prescription Drugs Sales and Sales Share by Application (2013-2018)
8.4.2 South America Anti-Obesity Prescription Drugs Revenue and Revenue Share by Application (2013-2018)
9 Middle East and Africa Anti-Obesity Prescription Drugs by Countries, Type, Application and Manufacturers
9.1 Middle East and Africa Anti-Obesity Prescription Drugs Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Anti-Obesity Prescription Drugs Sales by Countries (2013-2018)
9.1.2 Middle East and Africa Anti-Obesity Prescription Drugs Revenue by Countries (2013-2018)
9.1.3 Saudi Arabia Anti-Obesity Prescription Drugs Sales and Growth Rate (2013-2018)
9.1.4 UAE Anti-Obesity Prescription Drugs Sales and Growth Rate (2013-2018)
9.1.5 Egypt Anti-Obesity Prescription Drugs Sales and Growth Rate (2013-2018)
9.1.6 Nigeria Anti-Obesity Prescription Drugs Sales and Growth Rate (2013-2018)
9.1.7 South Africa Anti-Obesity Prescription Drugs Sales and Growth Rate (2013-2018)
9.2 Middle East and Africa Anti-Obesity Prescription Drugs Sales and Revenue (Value) by Manufacturers (2016-2017)
9.2.1 Middle East and Africa Anti-Obesity Prescription Drugs Sales by Manufacturers (2016-2017)
9.2.2 Middle East and Africa Anti-Obesity Prescription Drugs Revenue by Manufacturers (2016-2017)
9.3 Middle East and Africa Anti-Obesity Prescription Drugs Sales, Revenue and Market Share by Type (2013-2018)
9.3.1 Middle East and Africa Anti-Obesity Prescription Drugs Sales and Sales Share by Type (2013-2018)
9.3.1 Middle East and Africa Anti-Obesity Prescription Drugs Revenue and Revenue Share by Type (2013-2018)
9.4 Middle East and Africa Anti-Obesity Prescription Drugs Sales, Revenue and Market Share by Application (2013-2018)
9.4.1 Middle East and Africa Anti-Obesity Prescription Drugs Sales and Sales Share by Application (2013-2018)
9.4.2 Middle East and Africa Anti-Obesity Prescription Drugs Revenue and Revenue Share by Application (2013-2018)
10 Global Anti-Obesity Prescription Drugs Market Segment by Type
10.1 Global Anti-Obesity Prescription Drugs Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Anti-Obesity Prescription Drugs Sales and Market Share by Type (2013-2018)
10.1.2 Global Anti-Obesity Prescription Drugs Revenue and Market Share by Type (2013-2018)
10.2 Orlistat Sales Growth and Price
10.2.1 Global Orlistat Sales Growth (2013-2018)
10.2.2 Global Orlistat Price (2013-2018)
10.3 Phentermine and Topiramate Sales Growth and Price
10.3.1 Global Phentermine and Topiramate Sales Growth (2013-2018)
10.3.2 Global Phentermine and Topiramate Price (2013-2018)
10.4 Bupropion and Naltrexone Sales Growth and Price
10.4.1 Global Bupropion and Naltrexone Sales Growth (2013-2018)
10.4.2 Global Bupropion and Naltrexone Price (2013-2018)
10.5 Lorcaserin Sales Growth and Price
10.5.1 Global Lorcaserin Sales Growth (2013-2018)
10.5.2 Global Lorcaserin Price (2013-2018)
10.6 Liraglutide Sales Growth and Price
10.6.1 Global Liraglutide Sales Growth (2013-2018)
10.6.2 Global Liraglutide Price (2013-2018)
11 Global Anti-Obesity Prescription Drugs Market Segment by Application
11.1 Global Anti-Obesity Prescription Drugs Sales Market Share by Application (2013-2018)
11.2 Pediatric Sales Growth (2013-2018)
11.3 Adult Sales Growth (2013-2018)
12 Anti-Obesity Prescription Drugs Market Forecast (2018-2023)
12.1 Global Anti-Obesity Prescription Drugs Sales, Revenue and Growth Rate (2018-2023)
12.2 Anti-Obesity Prescription Drugs Market Forecast by Regions (2018-2023)
12.2.1 North America Anti-Obesity Prescription Drugs Market Forecast (2018-2023)
12.2.2 Europe Anti-Obesity Prescription Drugs Market Forecast (2018-2023)
12.2.3 Asia-Pacific Anti-Obesity Prescription Drugs Market Forecast (2018-2023)
12.2.4 South America Anti-Obesity Prescription Drugs Market Forecast (2018-2023)
12.2.5 Middle East and Africa Anti-Obesity Prescription Drugs Market Forecast (2018-2023)
12.3 Anti-Obesity Prescription Drugs Market Forecast by Type (2018-2023)
12.3.1 Global Anti-Obesity Prescription Drugs Sales Forecast by Type (2018-2023)
12.3.2 Global Anti-Obesity Prescription Drugs Market Share Forecast by Type (2018-2023)
12.4 Anti-Obesity Prescription Drugs Market Forecast by Application (2018-2023)
12.4.1 Global Anti-Obesity Prescription Drugs Sales Forecast by Application (2018-2023)
12.4.2 Global Anti-Obesity Prescription Drugs Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Anti-Obesity Prescription Drugs Picture
Table Product Specifications of Anti-Obesity Prescription Drugs
Figure Global Anti-Obesity Prescription Drugs CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (USD Million)
Figure Global Anti-Obesity Prescription Drugs CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (Sales)
Figure Global Sales Market Share of Anti-Obesity Prescription Drugs by Types in 2017
Figure Orlistat Picture
Table Major Manufacturers of Orlistat
Figure Phentermine and Topiramate Picture
Table Major Manufacturers of Phentermine and Topiramate
Figure Bupropion and Naltrexone Picture
Table Major Manufacturers of Bupropion and Naltrexone
Figure Lorcaserin Picture
Table Major Manufacturers of Lorcaserin
Figure Liraglutide Picture
Table Major Manufacturers of Liraglutide
Figure Anti-Obesity Prescription Drugs Sales Market Share by Applications in 2017
Figure Pediatric Picture
Figure Adult Picture
Figure United States Anti-Obesity Prescription Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Anti-Obesity Prescription Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Anti-Obesity Prescription Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Anti-Obesity Prescription Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure France Anti-Obesity Prescription Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure UK Anti-Obesity Prescription Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Anti-Obesity Prescription Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Anti-Obesity Prescription Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure China Anti-Obesity Prescription Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Anti-Obesity Prescription Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Anti-Obesity Prescription Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure India Anti-Obesity Prescription Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Anti-Obesity Prescription Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Anti-Obesity Prescription Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Anti-Obesity Prescription Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Anti-Obesity Prescription Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Anti-Obesity Prescription Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Anti-Obesity Prescription Drugs Revenue (Value) and Growth Rate (2013-2023)
Table F Hoffmann La Roche Ltd Headquarter, Established, Main Business and Finance Overview (2017)
Table F Hoffmann La Roche Ltd Anti-Obesity Prescription Drugs Production Bases, Sales Regions and Major Competitors
Table F Hoffmann La Roche Ltd Anti-Obesity Prescription Drugs Product
Table F Hoffmann La Roche Ltd Anti-Obesity Prescription Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global F Hoffmann La Roche Ltd Anti-Obesity Prescription Drugs Sales Market Share in 2017
Figure Global F Hoffmann La Roche Ltd Anti-Obesity Prescription Drugs Revenue Market Share in 2017
Table Orexigen Therapeutics, Inc Headquarter, Established, Main Business and Finance Overview (2017)
Table Orexigen Therapeutics, Inc Anti-Obesity Prescription Drugs Production Bases, Sales Regions and Major Competitors
Table Orexigen Therapeutics, Inc Anti-Obesity Prescription Drugs Product
Table Orexigen Therapeutics, Inc Anti-Obesity Prescription Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Orexigen Therapeutics, Inc Anti-Obesity Prescription Drugs Sales Market Share in 2017
Figure Global Orexigen Therapeutics, Inc Anti-Obesity Prescription Drugs Revenue Market Share in 2017
Table Novo Nordisk A/s Headquarter, Established, Main Business and Finance Overview (2017)
Table Novo Nordisk A/s Anti-Obesity Prescription Drugs Production Bases, Sales Regions and Major Competitors
Table Novo Nordisk A/s Anti-Obesity Prescription Drugs Product
Table Novo Nordisk A/s Anti-Obesity Prescription Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Novo Nordisk A/s Anti-Obesity Prescription Drugs Sales Market Share in 2017
Figure Global Novo Nordisk A/s Anti-Obesity Prescription Drugs Revenue Market Share in 2017
Table Arena Pharmaceuticals, Inc Headquarter, Established, Main Business and Finance Overview (2017)
Table Arena Pharmaceuticals, Inc Anti-Obesity Prescription Drugs Production Bases, Sales Regions and Major Competitors
Table Arena Pharmaceuticals, Inc Anti-Obesity Prescription Drugs Product
Table Arena Pharmaceuticals, Inc Anti-Obesity Prescription Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Arena Pharmaceuticals, Inc Anti-Obesity Prescription Drugs Sales Market Share in 2017
Figure Global Arena Pharmaceuticals, Inc Anti-Obesity Prescription Drugs Revenue Market Share in 2017
Table Glaxosmithkline Headquarter, Established, Main Business and Finance Overview (2017)
Table Glaxosmithkline Anti-Obesity Prescription Drugs Production Bases, Sales Regions and Major Competitors
Table Glaxosmithkline Anti-Obesity Prescription Drugs Product
Table Glaxosmithkline Anti-Obesity Prescription Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Glaxosmithkline Anti-Obesity Prescription Drugs Sales Market Share in 2017
Figure Global Glaxosmithkline Anti-Obesity Prescription Drugs Revenue Market Share in 2017
Table Vivus, Inc Headquarter, Established, Main Business and Finance Overview (2017)
Table Vivus, Inc Anti-Obesity Prescription Drugs Production Bases, Sales Regions and Major Competitors
Table Vivus, Inc Anti-Obesity Prescription Drugs Product
Table Vivus, Inc Anti-Obesity Prescription Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Vivus, Inc Anti-Obesity Prescription Drugs Sales Market Share in 2017
Figure Global Vivus, Inc Anti-Obesity Prescription Drugs Revenue Market Share in 2017
Table Boehringer Ingelheim Headquarter, Established, Main Business and Finance Overview (2017)
Table Boehringer Ingelheim Anti-Obesity Prescription Drugs Production Bases, Sales Regions and Major Competitors
Table Boehringer Ingelheim Anti-Obesity Prescription Drugs Product
Table Boehringer Ingelheim Anti-Obesity Prescription Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Boehringer Ingelheim Anti-Obesity Prescription Drugs Sales Market Share in 2017
Figure Global Boehringer Ingelheim Anti-Obesity Prescription Drugs Revenue Market Share in 2017
Table Alizyme Headquarter, Established, Main Business and Finance Overview (2017)
Table Alizyme Anti-Obesity Prescription Drugs Production Bases, Sales Regions and Major Competitors
Table Alizyme Anti-Obesity Prescription Drugs Product
Table Alizyme Anti-Obesity Prescription Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Alizyme Anti-Obesity Prescription Drugs Sales Market Share in 2017
Figure Global Alizyme Anti-Obesity Prescription Drugs Revenue Market Share in 2017
Table Global Anti-Obesity Prescription Drugs Sales by Manufacturer (2016-2017)
Figure Global Anti-Obesity Prescription Drugs Sales Market Share by Manufacturer in 2016
Figure Global Anti-Obesity Prescription Drugs Sales Market Share by Manufacturer in 2017
Table Global Anti-Obesity Prescription Drugs Revenue by Manufacturer (2016-2017)
Figure Global Anti-Obesity Prescription Drugs Revenue Market Share by Manufacturer in 2016
Figure Global Anti-Obesity Prescription Drugs Revenue Market Share by Manufacturer in 2017
Table Global Anti-Obesity Prescription Drugs Price by Manufacturer (2016-2017)
Figure Top 3 Anti-Obesity Prescription Drugs Manufacturer (Revenue) Market Share in 2017
Figure Top 6 Anti-Obesity Prescription Drugs Manufacturer (Revenue) Market Share in 2017
Figure Global Anti-Obesity Prescription Drugs Sales and Growth Rate (2013-2018)
Figure Global Anti-Obesity Prescription Drugs Revenue and Growth Rate (2013-2018)
Table Global Anti-Obesity Prescription Drugs Sales by Regions (2013-2018)
Table Global Anti-Obesity Prescription Drugs Sales Market Share by Regions (2013-2018)
Table Global Anti-Obesity Prescription Drugs Revenue by Regions (2013-2018)
Figure Global Anti-Obesity Prescription Drugs Revenue Market Share by Regions in 2013
Figure Global Anti-Obesity Prescription Drugs Revenue Market Share by Regions in 2017
Figure North America Anti-Obesity Prescription Drugs Sales and Growth Rate (2013-2018)
Figure North America Anti-Obesity Prescription Drugs Revenue and Growth Rate (2013-2018)
Figure Europe Anti-Obesity Prescription Drugs Sales and Growth Rate (2013-2018)
Figure Europe Anti-Obesity Prescription Drugs Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Anti-Obesity Prescription Drugs Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Anti-Obesity Prescription Drugs Revenue and Growth Rate (2013-2018)
Figure South America Anti-Obesity Prescription Drugs Sales and Growth Rate (2013-2018)
Figure South America Anti-Obesity Prescription Drugs Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Anti-Obesity Prescription Drugs Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Anti-Obesity Prescription Drugs Revenue and Growth Rate (2013-2018)
Figure North America Anti-Obesity Prescription Drugs Revenue and Growth Rate (2013-2018)
Table North America Anti-Obesity Prescription Drugs Sales by Countries (2013-2018)
Table North America Anti-Obesity Prescription Drugs Sales Market Share by Countries (2013-2018)
Figure North America Anti-Obesity Prescription Drugs Sales Market Share by Countries in 2013
Figure North America Anti-Obesity Prescription Drugs Sales Market Share by Countries in 2017
Table North America Anti-Obesity Prescription Drugs Revenue by Countries (2013-2018)
Table North America Anti-Obesity Prescription Drugs Revenue Market Share by Countries (2013-2018)
Figure North America Anti-Obesity Prescription Drugs Revenue Market Share by Countries in 2013
Figure North America Anti-Obesity Prescription Drugs Revenue Market Share by Countries in 2017
Figure United States Anti-Obesity Prescription Drugs Sales and Growth Rate (2013-2018)
Figure Canada Anti-Obesity Prescription Drugs Sales and Growth Rate (2013-2018)
Figure Mexico Anti-Obesity Prescription Drugs Sales and Growth Rate (2013-2018)
Table North America Anti-Obesity Prescription Drugs Sales by Manufacturer (2016-2017)
Figure North America Anti-Obesity Prescription Drugs Sales Market Share by Manufacturer in 2016
Figure North America Anti-Obesity Prescription Drugs Sales Market Share by Manufacturer in 2017
Table North America Anti-Obesity Prescription Drugs Revenue by Manufa
Global Antioxidant Vitamins Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 100
The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
Global Clavulanate Potassium Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 86
The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030.
North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
Global Amoxicillin Sodium Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 84
The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030.
North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
Global Melatonin Supplements Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 106
The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 93
The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
Global Sleeping Pills Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 94
The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
Global Zinc Oral Drops Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 85
The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
Global Zinc Drops Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 85
The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
Global Anti-Infectives Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 78
The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
